Send Enquiry

CURE
Tablets
Packaging and packing Type
Blister | 10x10
MRP :
₹165.94
PTR :
₹126.43
PTS :
₹113.79
Prescription medicine Read More
Composition
Send Enquiry
India’s Trusted Pharma Brand
100%
Genuine Products
Secure
Payments
24 x 7
Customer Support
About the product
By Vibcare Pharma · Updated 9 October 2026 · Based on product labels and standard drug references
Fenovib 145 is a tablet from Vibcare Pharma. Each tablet carries Fenofibrate 145 mg, a medicine of the fibrate class used to correct blood lipid levels. It is packed as 10x10 (Blister) and comes from Vibcare Pharma.
Fenofibrate acts on the PPAR alpha receptor in the liver. It raises the activity of lipoprotein lipase and lowers apoprotein C-III, so triglyceride-rich particles are broken down and cleared from the blood. As triglycerides fall, LDL particles change from small dense forms to larger ones.
The tablets are used with diet in adults with primary hypercholesterolemia or mixed dyslipidemia to bring down LDL cholesterol, total cholesterol, triglycerides and apolipoprotein B and to raise HDL cholesterol, and in severe hypertriglyceridemia. Serious liver injury has been reported, so liver function should be checked before starting and during treatment. Muscle pain or weakness with dark urine needs urgent medical help, and the muscle risk is higher when the tablet is taken with a statin.
Use only on a doctor's prescription, at the dose and for the duration advised.
Common
Get medical help at once if you notice
Do not use
Ask a doctor first
Fenovib 145 tablets contain Fenofibrate 145 mg and are used with diet to correct raised cholesterol and triglyceride levels in adults. Main uses: adjunct to diet to reduce raised LDL cholesterol (LDL-C) in adults; adjunct to diet to reduce raised total cholesterol (Total-C) in adults; adjunct to diet to reduce raised triglycerides (TG) in adults; adjunct to diet to reduce raised apolipoprotein B (Apo B) in adults; adjunct to diet to increase HDL cholesterol (HDL-C) in adults.
Common side effects of Fenovib 145 Tablet include abnormal liver function tests; increased AST; increased ALT; increased CPK; rhinitis; abdominal pain. Get medical help at once if you notice serious drug-induced liver injury, including cases requiring liver transplantation and death; myopathy and rhabdomyolysis, more so when taken together with a statin; pancreatitis.
Each Fenovib 145 tablet contains Fenofibrate 145 mg. The right dose and how long to take it depend on the condition, age and other medicines, so use Fenovib 145 Tablet only as your doctor advises.
The MRP of Fenovib 145 Tablet is ₹165.94 for a pack of 10x10 (Blister). For chemists and distributors, the PTR is ₹126.43 and the PTS is ₹113.79.
Each Fenovib 145 tablet contains Fenofibrate 145 mg. It comes in a pack of 10x10 (Blister).
Fenofibrate acts on the PPAR alpha receptor in the liver. It raises the activity of lipoprotein lipase and lowers apoprotein C-III, so triglyceride-rich particles are broken down and cleared from the blood. As triglycerides fall, LDL particles change from small dense forms to larger ones.
Must not be used in patients with severe renal impairment, including those receiving dialysis. Must not be used in patients with active liver disease, including primary biliary cirrhosis or unexplained persistent liver function abnormalities. Must not be used in patients with pre-existing gallbladder disease. Must not be used by nursing mothers. Must not be used by anyone with known hypersensitivity to fenofibrate or fenofibric acid.
Fenovib 145 Tablet is a brand of Vibcare Pharma, sold through its Cure division. It is available for PCD pharma franchise and distribution in India; use the Send Enquiry or WhatsApp button on this page to ask about availability and terms.
Send Enquiry
Request a callback to get more information about becoming a PCD Franchise Owner